Clinical trial

Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney…

NCT00433953 · Children's Hospital Medical Center, Cincinnati, Other · Terminated

Key facts

NCT number NCT00433953
Title Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
Official title Pharmacogenetics of Mycophenolic Acid in Kidney Transplant Patients
Lead sponsor Children's Hospital Medical Center, Cincinnati, Other
Status Terminated
Phase Phase 1
Study type Interventional
Conditions Kidney Transplant
Intervention type Behavioral, Drug, Procedure
Interventions Mycophenolate Mofetil (CellCept), Dietary Monitoring, Drug Diary, Blood Sampling
Enrollment 44
Start date Feb 1, 2007
Primary completion Feb 1, 2010
Completion Feb 1, 2010
First posted Feb 12, 2007
Last update posted Feb 20, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies